Detalhe da pesquisa
1.
Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.
Int J Neuropsychopharmacol
; 20(4): 285-294, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031269
2.
Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies.
J Hum Genet
; 60(6): 319-26, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25855068
3.
Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes.
Stem Cell Reports
; 8(2): 226-234, 2017 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111276
4.
[Use of GWAS for drug discovery and development].
Yakugaku Zasshi
; 134(4): 485-90, 2014.
Artigo
em Japonês
| MEDLINE | ID: mdl-24694807
5.
The impact of pharmacogenomics research on drug development.
Drug Metab Pharmacokinet
; 27(1): 2-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22214937
6.
[Role of pharmacogenomics in translation research].
Nihon Yakurigaku Zasshi
; 141(3): 131-5, 2013 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-23470477
7.
Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia.
J Biol Chem
; 277(7): 4816-22, 2002 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11719510